SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-006383
Filing Date
2023-04-21
Accepted
2023-04-21 08:30:15
Documents
6
Period of Report
2023-05-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20230519xdef14a.htm DEF 14A 1081784
2 GRAPHIC tmb-20230519xdef14a_a001.jpg GRAPHIC 3755
3 GRAPHIC tmb-20230519xdef14a_a009.jpg GRAPHIC 34459
4 GRAPHIC tmb-20230519xdef14a_a010.jpg GRAPHIC 33490
5 GRAPHIC tmb-20230519xdef14a_bg001.jpg GRAPHIC 116269
6 GRAPHIC tmb-20230519xdef14a_bg002.jpg GRAPHIC 104255
  Complete submission text file 0001558370-23-006383.txt   1485968
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36177 | Film No.: 23834651
SIC: 2834 Pharmaceutical Preparations